Oncology Nutrition Market Analysis

Oncology nutrition Market Analysis

Based on the cancer type, the global market is classified into head and neck cancer, stomach and gastrointestinal cancer, esophageal cancer, liver cancer, breast cancer, pancreatic cancer, lung cancer, and other cancer types. The stomach and gastrointestinal cancer segment dominated the market with revenue of USD 472 million in 2023.
 

• The rise in the prevalence of gastrointestinal cancer, owing to poor dietary habits such as high consumption of processed foods, red meats, and low intake of fruits and vegetables rises the demand for specialized nutrition to support patients undergoing treatment also increases.
   
• Moreover, with the rise in awareness about nutritional support, the adoption of specialized nutrition products tailored to the needs of cancer patients, including those with stomach and gastrointestinal cancers increases.
   

Based on the product type, the global oncology nutrition market is classified into vitamins and minerals, proteins, antioxidants, and other product types. The proteins segment dominated the market with market share of 33.5% in 2023.
 

• With the increase in prevalence of cancer, healthcare providers are increasingly recognizing the importance of nutritional support as part of cancer treatment. Protein-rich diets are often recommended to help maintain muscle mass, prevent weight loss, and support overall health during cancer therapy.
   
• Additionally, companies in the healthcare and nutrition sectors are continually innovating to develop new and improved oncology nutrition products tailored to the specific needs of cancer patients. This includes protein supplements formulated with optimal nutrient compositions and flavors to enhance palatability.
   

Based on formulation, the oncology nutrition market is classified into standard and elemental. Standard segment is expected to exhibit 8.5% CAGR between 2024 - 2032.
 

• Developed to fulfill precise needs, standard oncology nutrition formulas are crafted to supply vital nutrients and calories essential for sustaining overall health and wellness. Consequently, heightened awareness regarding the role of adequate nutrition in mitigating side effects of cancer treatment, enhancing quality of life, and improving treatment outcomes has emerged among individuals. This underscores the importance of tailored oncology nutrition formulas designed to meet these needs, particularly for elderly cancer patients, thereby driving market expansion in the foreseeable future.
   

Based on route of administration, the oncology nutrition market is classified into oral and parenteral. Oral segment is expected to reach 2.6 billion by 2032.
 

• The surge in technological advancement has led to the development of oral nutritional supplements with enhanced palatability, better absorption, and increased nutrient content, making them more appealing and effective for cancer patients. Also, many patients prefer oral nutritional supplements over alternative routes like parenteral (intravenous) nutrition due to convenience and ease of administration, which can drive the demand for oral products.
   

Based on dosage type, the oncology nutrition market is classified into liquid, powder, and other dosage types. Liquid segment accounted with market share of 42.1% in 2023.
 

• Patients with cancer often experience gastrointestinal issues such as nausea, vomiting, or mucositis, which can make swallowing solid dosage forms challenging. Therefore, in such cases liquid dosage form provide better compliance absorbed more quickly and efficiently by the body compared to solid forms, ensuring patients receive vital nutrients, thereby augmenting the growth of the market in the coming years.
   

Based on end-use, the oncology nutrition market is classified into hospitals, clinics, homecare, and other end-users. Hospitals segment is expected to exhibit 8.5% CAGR between 2024 - 2032.
 

• With the rise in prevalence of cancer, hospitals witness a growing number of cancer patients seeking treatment, necessitating specialized nutrition interventions to support their health during treatment and recovery. Thus, the hospitals are increasingly focusing on providing comprehensive care for cancer patients, including nutrition support as an integral part of treatment plans. This emphasis drives the demand for oncology nutrition services within hospital settings, thereby fostering the segmental growth. 
   

In 2023, North America secured a substantial market share of 42.7% in the global market and is expected to dominate throughout the forecast period.
 

• Supportive care initiatives in North America prioritize enhancing patient outcomes for those suffering with cancer. Therefore, nutrition plays a crucial role in such care, resulting in an increased need for specialized oncology nutritional interventions.
   
• Furthermore, governmental efforts and healthcare policies in North America underscore the significance of comprehensive cancer care, encompassing nutritional support.